A Phase 1a-b Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer
Phase of Trial: Phase I
Latest Information Update: 11 Aug 2017
At a glance
- Drugs BMX 001 (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Adverse reactions
- Acronyms BMX-HN
- Sponsors BioMimetix
- 18 Apr 2017 Planned End Date changed from 1 Jul 2019 to 1 Apr 2019.
- 18 Apr 2017 Planned primary completion date changed from 1 Jan 2019 to 1 Apr 2019.
- 18 Apr 2017 Status changed from not yet recruiting to recruiting.